XML 94 R74.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation (Performance Shares, RSUs, Restricted Stock and Share Unit Awards) (Details)
12 Months Ended
Jul. 31, 2017
$ / shares
shares
Jul. 31, 2020
USD ($)
$ / shares
shares
Jul. 31, 2019
USD ($)
$ / shares
shares
Jul. 31, 2018
USD ($)
$ / shares
shares
Jul. 31, 2016
Dividend Equivalents [Abstract]          
Accrued during the period | $   $ 294,000 $ 327,000 $ 300,000  
Carrying value at period end | $   380,348,000 352,629,000    
Income tax benefit from settlement of stock-based awards | $   $ 224,000 $ 479,000 $ 1,193,000  
Performance Shares, RSUs, Restricted Stock and Share Units          
Awards (In Shares)          
Outstanding, Beginning Balance (in shares)   954,676 818,438 830,197  
Granted (in shares)   560,361 442,363 473,005  
Settled (in shares)   (431,581) (275,619) (354,822)  
Forfeited (in shares)   (83,882) (30,506) (129,942)  
Outstanding, Ending Balance (in shares) 830,197 999,574 954,676 818,438  
Vested, Ending Balance (in shares)   429,191      
Vested and Expected to Vest, Ending Balance (in shares)   964,807      
Weighted Average Grant Date Fair Value          
Outstanding, Beginning Balance (in dollars per share) | $ / shares   $ 22.40 $ 19.78 $ 16.95  
Granted (in dollars per share) | $ / shares   19.93 29.76 22.45  
Settled (in dollars per share) | $ / shares   22.02 26.05 17.66  
Forfeited (in dollars per share) | $ / shares   22.84 25.52 17.26  
Outstanding, Ending Balance (in dollars per share) | $ / shares $ 16.95 21.15 $ 22.40 $ 19.78  
Vested, Ending Balance (in dollars per share) | $ / shares   16.22      
Vested and Expected to Vest, Ending Balance (in dollars per share) | $ / shares   $ 21.10      
Aggregate Intrinsic Value          
Outstanding, Ending Balance | $   $ 16,413,000      
Vested, Ending Balance | $   7,047,000      
Vested and Expected to Vest, Ending Balance | $   15,842,000      
Additional Disclosures          
Total intrinsic value relating to fully vested stock-based awards converted during the period | $   $ 9,635,000 $ 8,772,000 $ 10,473,000  
Performance shares | Employees | Granted since fiscal 2014          
Additional Disclosures          
Performance period (in years)   3 years      
RSUs and restricted stock | Employees          
Additional Disclosures          
Vesting period (in years)   5 years      
Common stock, conversion ratio (in shares)   1      
RSUs and restricted stock | Non-Employee Director          
Additional Disclosures          
Vesting period (in years)   5 years   3 years  
Common stock, conversion ratio (in shares)       1  
Share units          
Awards (In Shares)          
Granted (in shares)   330,696      
Additional Disclosures          
Common stock, conversion ratio (in shares)         1
Conversion period of vested share units 1 year        
Granted units converted into common stock (in shares)   223,739      
Number of shares issued as result of conversion   81,507      
Number of units settled to date (in shares)   658,583      
Dividend equivalents          
Dividend Equivalents [Abstract]          
Accrued during the period | $   $ 294,000 327,000 $ 300,000  
Paid during the period | $   288,000 263,000 $ 141,000  
Carrying value at period end | $   $ 783,000 $ 777,000